Diversified Healthcare Trust (DHC)
NASDAQ: DHC · Real-Time Price · USD
7.02
-0.01 (-0.14%)
Nov 6, 2026, 4:00 PM EST - Market closed
DHC Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Rental Revenue | 200.62 | 225.2 | 251.04 | 258.4 | 260.74 | 408.59 |
Other Revenue | 1,278 | 1,313 | 1,244 | 1,152 | 1,023 | 974.62 |
| 1,479 | 1,538 | 1,495 | 1,410 | 1,284 | 1,383 | |
Revenue Growth (YoY | -3.82% | 2.84% | 6.04% | 9.87% | -7.20% | -15.25% |
Property Expenses | 1,185 | 1,270 | 1,239 | 1,185 | 1,112 | 1,109 |
Selling, General & Administrative | 60.55 | 45.5 | 26.52 | 26.13 | 26.44 | 34.09 |
Depreciation & Amortization | 250.33 | 261.92 | 284.96 | 284.08 | 239.28 | 271.13 |
Total Operating Expenses | 1,496 | 1,577 | 1,551 | 1,495 | 1,377 | 1,415 |
Operating Income | -16.41 | -39.27 | -55.1 | -84.91 | -93.82 | -31.32 |
Interest Expense | -158.15 | -204.5 | -235.24 | -191.78 | -209.38 | -255.76 |
Interest & Investment Income | 2.45 | 5.84 | 8.95 | 13.96 | 11.63 | 1.04 |
Income (Loss) on Equity Investments | 31.76 | 36.76 | 1.6 | -20.46 | 6.06 | - |
EBT Excluding Unusual Items | -140.34 | -201.17 | -279.79 | -283.19 | -285.52 | -286.05 |
Gain (Loss) on Sale of Investments | - | - | - | 8.13 | -25.66 | -42.23 |
Gain (Loss) on Sale of Assets | 11.03 | 117.73 | -18.94 | 1.21 | 321.86 | 492.27 |
Total Insurance Settlements | - | 7.52 | - | - | - | - |
Asset Writedown | -17.54 | -165.7 | -70.73 | -18.38 | - | 0.17 |
Other Unusual Items | -2.14 | -42.53 | -0.32 | -0.89 | -25.74 | 17.19 |
Pretax Income | -148.99 | -284.14 | -369.79 | -293.13 | -15.06 | 181.36 |
Income Tax Expense | 3.16 | 1.74 | 0.47 | 0.45 | 0.71 | 1.43 |
Earnings From Continuing Operations | -152.14 | -285.89 | -370.26 | -293.57 | -15.77 | 179.93 |
Net Income to Company | -152.14 | -285.89 | -370.26 | -293.57 | -15.77 | 179.93 |
Minority Interest in Earnings | - | - | - | - | - | -5.41 |
Net Income | -152.14 | -285.89 | -370.26 | -293.57 | -15.77 | 174.52 |
Net Income to Common | -152.14 | -285.89 | -370.26 | -293.57 | -15.77 | 174.52 |
Net Income Growth | - | - | - | - | - | - |
Basic Shares Outstanding | 241 | 240 | 240 | 239 | 238 | 238 |
Diluted Shares Outstanding | 241 | 240 | 240 | 239 | 238 | 238 |
Shares Change | 0.28% | 0.31% | 0.29% | 0.22% | 0.15% | 0.10% |
EPS (Basic) | -0.63 | -1.19 | -1.55 | -1.23 | -0.07 | 0.73 |
EPS (Diluted) | -0.63 | -1.19 | -1.55 | -1.23 | -0.07 | 0.73 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share | 0.040 | 0.040 | 0.040 | 0.040 | 0.040 | 0.040 |
Dividend Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Operating Margin | -1.11% | -2.55% | -3.69% | -6.02% | -7.31% | -2.27% |
Profit Margin | -10.29% | -18.59% | -24.76% | -20.82% | -1.23% | 12.62% |
EBITDA | 234.01 | 222.77 | 229.96 | 198.93 | 145.7 | 232.6 |
EBITDA Margin | 15.82% | 14.49% | 15.38% | 14.11% | 11.35% | 16.82% |
D&A For Ebitda | 250.42 | 262.04 | 285.06 | 283.84 | 239.53 | 263.92 |
EBIT | -16.41 | -39.27 | -55.1 | -84.91 | -93.82 | -31.32 |
EBIT Margin | -1.11% | -2.55% | -3.68% | -6.02% | -7.31% | -2.26% |
Funds From Operations (FFO) | 80.94 | 2.6 | 25.59 | 26.17 | -74.95 | -30.9 |
FFO Per Share | - | - | - | - | -0.31 | -0.13 |
Adjusted Funds From Operations (AFFO) | - | 2.6 | 25.59 | 26.17 | -74.95 | -30.9 |
AFFO Per Share | - | - | - | - | -0.31 | -0.13 |
FFO Payout Ratio | 11.97% | 372.01% | 37.62% | 36.66% | - | - |
Effective Tax Rate | - | - | - | - | - | 0.79% |
Revenue as Reported | 1,479 | 1,538 | 1,495 | 1,410 | 1,284 | 1,383 |